Literature DB >> 33819742

Autoimmunity, IgE and FcεRI-bearing cells.

Nicolas Charles1.   

Abstract

Antibody-mediated autoimmune diseases (AAID) involve several isotypes of autoreactive antibodies. In a growing number of AAID, autoreactive IgE are present with a significant prevalence and are often associated with the presence of IgG anti-IgE and/or anti-FcεRIα (high affinity IgE receptor α chain). FcεRI-bearing cells, such as basophils or mast cells, are key players in some of these AAID. Recent advances in the pathophysiology of these diseases led to the passed or current development of anti-IgE strategies that showed very potent effects in some of them. The present review centralizes the information on the relevance of autoreactive IgE and FcεRI-bearing cells in the pathophysiology of different AAID and the ones where the anti-IgE therapeutic strategy shows or may show some benefits for the patients.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33819742     DOI: 10.1016/j.coi.2021.03.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  3 in total

1.  CT-M8 Mice: A New Mouse Model Demonstrates That Basophils Have a Nonredundant Role in Lupus-Like Disease Development.

Authors:  John Tchen; Quentin Simon; Léa Chapart; Christophe Pellefigues; Hajime Karasuyama; Kensuke Miyake; Ulrich Blank; Marc Benhamou; Eric Daugas; Nicolas Charles
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 2.  Role of Basophils in a Broad Spectrum of Disorders.

Authors:  Kensuke Miyake; Junya Ito; Hajime Karasuyama
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  AMG853, A Bispecific Prostaglandin D2 Receptor 1 and 2 Antagonist, Dampens Basophil Activation and Related Lupus-Like Nephritis Activity in Lyn-Deficient Mice.

Authors:  Christophe Pellefigues; John Tchen; Chaimae Saji; Yasmine Lamri; Nicolas Charles
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.